| ACTG1 |
ACTB: Actin, cytoplasmic 1 |
TMSB4X |
TMSB4X, TB4X, THYB4, TMSB4: Thymosin beta-4 |
1.572 |
Evidence |
|
| F12 |
F12: Coagulation factor XII precursor |
APOH |
APOH, B2G1: Beta-2-glycoprotein 1 precursor |
1.572 |
Evidence |
O
|
| RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
MAPT |
IPI00217976 |
1.565 |
Evidence |
|
| TBP |
TBP, GTF2D1, TF2D, TFIID: TATA-box-binding protein |
TAF1L |
TAF1L: Transcription initiation factor TFIID 210 kDa subunit |
1.557 |
Evidence |
O
|
| POLR1C |
POLR1C, POLR1E: DNA-directed RNA polymerases I and III subunit RPAC1 |
POLR1D |
POLR1D: DNA-directed RNA polymerases I and III subunit RPAC2 |
1.557 |
Evidence |
O
|
| HIST1H4A |
HIST1H4A, H4/A, HIST1H4B, H4/I, H4/G, HIST1H4D, H4/B, H4/J, HIST1H4F, HIST4H4, H |
CDY1B |
IPI00218948 |
1.557 |
Evidence |
|
| HRK |
HRK, BID3: Activator of apoptosis harakiri |
BAD |
BAD, BBC6, BCL2L8: Bcl2 antagonist of cell death |
1.555 |
Evidence |
|
| SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
PIAS3 |
PIAS3: E3 SUMO-protein ligase PIAS3 |
1.547 |
Evidence |
|
| FOSL2 |
FOSL2, FRA2: Fos-related antigen 2 |
JUND |
JUND: Transcription factor jun-D |
1.54 |
Evidence |
O
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
MAPK8IP3 |
IPI00219817 |
1.532 |
Evidence |
|
| SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
STUB1 |
STUB1, CHIP, PP1131: STIP1 homology and U box-containing protein 1 |
1.532 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
CCR5 |
CCR5: CCR5 receptor (Fragment) |
1.53 |
Evidence |
|
| SP3 |
SP3: Transcription factor Sp3 |
RBBP4 |
RBBP4, RBAP48: Histone-binding protein RBBP4 |
1.527 |
Evidence |
O
|
| SUMO3 |
SUMO3, SMT3A, SMT3H1: Small ubiquitin-related modifier 3 precursor |
UBA2 |
SAE2, UBA2, HRIHFB2115, UBLE1B: SUMO-activating enzyme subunit 2 |
1.525 |
Evidence |
|
| HSPA8 |
HSPA8, HSC70, HSP73, HSPA10: Heat shock cognate 71 kDa protein |
DNAJA1 |
DNAJA1, DNAJ2, HDJ2, HSJ2, HSPF4: DnaJ homolog subfamily A member 1 |
1.52 |
Evidence |
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
CSNK2B |
CSNK2B, CK2N, G5A: Casein kinase II subunit beta |
1.52 |
Evidence |
|
| CASP3 |
CASP3, CPP32: Caspase-3 precursor |
PRKCZ |
PRKCZ, PKC2: Protein kinase C zeta type |
1.5 |
Evidence |
|
| COPS5 |
COPS5, CSN5, JAB1: COP9 signalosome complex subunit 5 |
CUL5 |
CUL5, VACM1: Cullin-5 |
1.495 |
Evidence |
|
| GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
RGS7 |
RGS7: Regulator of G-protein signaling 7 |
1.49 |
Evidence |
O
|
| PPFIA1 |
PPFIA1, LIP1: Liprin-alpha-1 |
PTPRD |
PTPRD: Protein tyrosine phosphatase receptor type D |
1.475 |
Evidence |
|
| C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
ARRB2 |
IPI00027355 |
1.47 |
Evidence |
|
| CTSG |
CTSG: Cathepsin G precursor |
CAMP |
CAMP, CAP18, HSD26, FALL39: Cathelicidin antimicrobial peptide precursor |
1.47 |
Evidence |
O
|
| DPP4 |
DPP4, ADCP2, CD26: Dipeptidyl peptidase 4 |
CCL11 |
CCL11, SCYA11: Eotaxin precursor |
1.455 |
Evidence |
|
| HTR1A |
HTR1A, ADRB2RL1, ADRBRL1: 5-hydroxytryptamine receptor 1A |
EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
1.44 |
Evidence |
O
|
| CSNK2A2 |
CSNK2A2, CK2A2: Casein kinase II subunit alpha' |
EEF1B2 |
EEF1B2, EEF1B, EF1B: Elongation factor 1-beta |
1.432 |
Evidence |
|
-